Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114676) titled 'Efficacy and Safety of Oliceridine in Conjunction with Etomidate for Hysteroscopic Surgery' on Dec. 16, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Qingdao Women and Children's Hospital (Peking University People's Hospital Qingdao Hospital)
Condition:
Gynecological disease
Intervention:
Oxaliplatin-combined with rimegepant group:Oxelizine 0.03mg/kg intravenously
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-10-01
Target Sample Size: Oxaliplatin-combined with rimegepant group:38;Sufentanil composite etomidate group:38;
Countries of R...